DekaBank Deutsche Girozentrale - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$88,000
+27.5%
22,5000.0%0.00%0.0%
Q3 2015$69,000
-24.2%
22,500
+4.7%
0.00%0.0%
Q2 2015$91,000
+15.2%
21,500
+4.9%
0.00%0.0%
Q1 2015$79,000
-49.7%
20,500
-12.8%
0.00%
-50.0%
Q4 2014$157,000
+12.1%
23,500
-7.8%
0.00%0.0%
Q3 2014$140,000
-45.3%
25,500
+2.0%
0.00%
-50.0%
Q2 2014$256,000
-16.3%
25,000
-2.0%
0.00%
-20.0%
Q1 2014$306,00025,5000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders